News

Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Fraud Investigation; CAPR Investors Urged to Contact Award-Winning Firm, Gibbs Mura
Shares of Capricor Therapeutics, Inc. plunged over 30% in intraday trading on Friday, July 11, 2025, after the U.S. Food and Drug Administration rejected the company’s Biologics License Application ...
Football.London on MSN13h
Tottenham summer spending and FFP position explained amid Morgan Gibbs-White delay
Tottenham Hotspur are looking to splash the cash this summer transfer window despite the obvious Financial Fair Play (FFP) concerns ...